Literature DB >> 24790661

Diagnostic approach of angelman syndrome.

Denis George Duca1, Dana Craiu2, Monica Boer2, Sorina Mihaela Chirieac3, Aurora Arghir3, Andreea Tutulan-Cunita3, Diana Barca2, Catrinel Iliescu2, Agripina Lungeanu3, Sanda Magureanu2, Magdalena Budisteanu4.   

Abstract

BACKGROUND: Angelman syndrome (AS) is a genetic condition, characterized by severe mental retardation, ataxic gait, severe speech delay, dysmorphic features, abnormal behaviour, movement disorder. It is caused by a variety of genetic mechanisms which all interfere with expression of the UBE3A gene on chromosome 15q11-13.
OBJECTIVES: To present our experience regarding diagnosis of children with Angelman syndrome.
MATERIAL AND METHODS: 15 children were clinically and genetically diagnosed with AS in the Department of Pediatric Neurology of the "Prof. Dr. Alex. Obregia" Clinical Hospital. In all cases, diagnosis of AS was made by the clinical criteria. The clinical evaluation focused on the patient history, a general examination, dysmorphological evaluation, a neurological examination, psychological evaluation, and paraclinical tests.
RESULTS: All patients from this study presented the characteristic facial features and the characteristic behavior phenotype. Psychomotor development was delayed in all children, most of cases (73%) presenting with sever mental retardation. Epileptic seizures were observed in all patients with microdeletion, the partial seizures being the most frequent type. EEG in all children showed the characteristic pattern for AS.
CONCLUSIONS: Angelman syndrome is a rare and severe neurodevelopmental disorder, with a complex clinical picture. There are some characteristic facial features, which, in association with hypopigmentation, happy disposition, jerky movements, and ataxia in a child with psychomotor delay should raise the strong suspicion of AS.

Entities:  

Year:  2013        PMID: 24790661      PMCID: PMC3968465     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  6 in total

1.  Angelman syndrome 2005: updated consensus for diagnostic criteria.

Authors:  Charles A Williams; Arthur L Beaudet; Jill Clayton-Smith; Joan H Knoll; Martin Kyllerman; Laura A Laan; R Ellen Magenis; Ann Moncla; Albert A Schinzel; Jane A Summers; Joseph Wagstaff
Journal:  Am J Med Genet A       Date:  2006-03-01       Impact factor: 2.802

Review 2.  Angelman syndrome without detectable chromosome 15q11-13 anomaly: clinical study of familial and isolated cases.

Authors:  L A Laan; D J Halley; A T den Boer; R C Hennekam; W O Renier; O F Brouwer
Journal:  Am J Med Genet       Date:  1998-03-19

3.  Clinical, cytogenetic, and molecular diagnosis of Angelman syndrome: estimated prevalence rate in a Danish county.

Authors:  M B Petersen; K Brøndum-Nielsen; L K Hansen; K Wulff
Journal:  Am J Med Genet       Date:  1995-06-19

4.  Diagnosis of Angelman syndrome: clinical and EEG criteria.

Authors:  S Buoni; S Grosso; L Pucci; A Fois
Journal:  Brain Dev       Date:  1999-07       Impact factor: 1.961

5.  A long-term population-based clinical and morbidity profile of Angelman syndrome in Western Australia: 1953-2003.

Authors:  A K Thomson; E J Glasson; A H Bittles
Journal:  Disabil Rehabil       Date:  2006-03-15       Impact factor: 3.033

Review 6.  Angelman syndrome: a review of the clinical and genetic aspects.

Authors:  J Clayton-Smith; L Laan
Journal:  J Med Genet       Date:  2003-02       Impact factor: 6.318

  6 in total
  1 in total

Review 1.  Angelman syndrome and melatonin: What can they teach us about sleep regulation.

Authors:  Daniella Buonfiglio; Daniel L Hummer; Ariel Armstrong; John Christopher Ehlen; Jason P DeBruyne
Journal:  J Pineal Res       Date:  2020-10-11       Impact factor: 13.007

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.